[Evaluation of interleukin-13 in the serum and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis].
Li Xiao, Zhenhua Li, Xian-ming Hou, Run-jiang Yu
Abstract
Li Xiao, Zhenhua Li, Xian-ming Hou, Run-jiang Yu
Abstract
OBJECTIVE: To study the significance of interleukin-13 (IL-13) in peripheral blood and bronchoalveolar lavage fluid (BALF) from patients with idiopathic pulmonary fibrosis (IPF). METHODS: The level of IL-13 was determined with ELISA in the serum and BALF of 17 patients with IPF and 8 subjects with non-interstitial lung diseases (non-smokers). RESULTS: The level of IL-13 in the BALF of the patients with IPF was significantly higher than that in non-interstitial lung disease group [(301 +/- 86) ng/L vs. (103 +/- 24) ng/L (P < 0.01)] and was higher than that in serum [(178 +/- 36) ng/L vs. (55 +/- 15) ng/L, P < 0.01]. The level of IL-13 in the BALF of the patients with IPF was positively correlated with the percentage of neutrophils (r = 0.786, P < 0.01). The analysis of Spearman correlation showed that the level of IL-13 in the BALF was correlated with lung function, PaO(2), and D(LCO) (Spearman correlation coefficient r = -0.898, -0.878, -0.874, -0.890, respectively, P < 0.01). CONCLUSION: IL-13 may play an important role in the pathogenesis of IPF and be a potential marker of IPF activity.
OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To study the significance of interleukin-13 (IL-13) in peripheral blood and bronchoalveolar lavage fluid (BALF) from patients with idiopathic pulmonary fibrosis (IPF). METHODS: The level of IL-13 was determined with ELISA in the serum and BALF of 17 patients with IPF and 8 subjects with non-interstitial lung diseases (non-smokers). RESULTS: The level of IL-13 in the BALF of the patients with IPF was significantly higher than that in non-interstitial lung disease group [(301 +/- 86) ng/L vs. (103 +/- 24) ng/L (P < 0.01)] and was higher than that in serum [(178 +/- 36) ng/L vs. (55 +/- 15) ng/L, P < 0.01]. The level of IL-13 in the BALF of the patients with IPF was positively correlated with the percentage of neutrophils (r = 0.786, P < 0.01). The analysis of Spearman correlation showed that the level of IL-13 in the BALF was correlated with lung function, PaO(2), and D(LCO) (Spearman correlation coefficient r = -0.898, -0.878, -0.874, -0.890, respectively, P < 0.01). CONCLUSION: IL-13 may play an important role in the pathogenesis of IPF and be a potential marker of IPF activity.
Key concepts: Bronchoalveolar lavage, Medicine, Idiopathic pulmonary fibrosis, Pathogenesis, Internal medicine, Gastroenterology, Interstitial lung disease, Pulmonary function testing